Prevest Denpro Ltd

Prevest Denpro Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Prevest Denpro Ltd

₹ 565 0.00%
01 Sep 1:25 p.m.
prevestdenpro.com BSE - SME: 543363
About

Incorporated in 2000, Prevest DenPro Limited is into development and manufacturing of dental materials used for diagnosis, prevention and treatment of dental conditions. Company is heavily export-oriented.

Key Points

Product Portfolio
Company manufactures over 100 dental products which comprise of:
a) Clinical Products: Adhesives, Bonding Agents & Etchants, Auxiliaries, Cement and Liners, Composites, Endodontics, Finishing & Polishing, Impression Materials, Oral Care, Orthodontics, Retraction Materials, Temporaries, and Tooth Whitening. [1]
b) Laboratory Products: Acrylics, Auxiliaries, Base Plates & Waxes, and Gypsum Products. [2]
Marquee Product - Resins: Company is the leading manufacturer of high-quality 3D printing resins designed for fabrication of dental crowns, bridges, inlays, onlays, and veneers. It offers several advantages over traditional fabrication methods.[3]
** Hygiene & Disinfectant** : This product is specifically formulated to combat a broad spectrum of pathogens, including bacteria, viruses, and fungi. These products are designed to target high-touch surfaces, medical devices, and equipment.[4]

Product Application
Their dental products find application in endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and for fabrication of prosthesis in dental laboratories. [5]
Prevest Denpro Limited operates with a business model focused on the manufacturing and distribution of dental materials and equipment.[6]

Website BSE
  • Market Cap ₹ 678 Cr.
  • Current Price ₹ 565
  • High / Low ₹ 686 / 394
  • Stock P/E 35.9
  • Book Value ₹ 88.0
  • Dividend Yield 0.18 %
  • ROCE 25.2 %
  • ROE 18.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
13.39 13.18 13.62 16.24 13.36 16.27 14.95 18.45 15.77
8.43 8.77 9.14 10.24 8.84 10.46 9.74 11.91 10.46
Operating Profit 4.96 4.41 4.48 6.00 4.52 5.81 5.21 6.54 5.31
OPM % 37.04% 33.46% 32.89% 36.95% 33.83% 35.71% 34.85% 35.45% 33.67%
0.61 0.74 0.68 0.84 0.86 1.04 1.09 1.08 1.17
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.17 0.22 0.42 0.46 0.48 0.47 0.48 0.47 0.49
Profit before tax 5.40 4.93 4.74 6.38 4.90 6.38 5.82 7.15 5.99
Tax % 24.26% 26.17% 23.21% 25.08% 25.10% 24.61% 22.16% 28.11% 26.38%
4.08 3.64 3.64 4.77 3.67 4.82 4.53 5.14 4.41
EPS in Rs 3.40 3.03 3.03 3.97 3.06 4.02 3.77 4.28 3.67
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025 TTM
56 63 65
36 41 43
Operating Profit 20 22 23
OPM % 36% 35% 35%
3 4 4
Interest 0 0 0
Depreciation 1 2 2
Profit before tax 21 24 25
Tax % 25% 25%
16 18 19
EPS in Rs 13.45 15.13 15.74
Dividend Payout % 7% 7%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 16%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 20%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 10%
1 Year: -3%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 19%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Equity Capital 12 12
Reserves 77 94
0 0
6 7
Total Liabilities 95 113
27 27
CWIP 0 0
Investments 2 5
66 81
Total Assets 95 113

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
12 15
-2 -1
-0 -1
Net Cash Flow 10 12

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Debtor Days 53 44
Inventory Days 168 240
Days Payable 32 48
Cash Conversion Cycle 189 236
Working Capital Days 79 82
ROCE % 25%

Shareholding Pattern

Numbers in percentages

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025
73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60% 73.60%
0.47% 0.21% 0.30% 0.26% 0.31% 0.31% 0.52% 1.11% 0.63% 0.63% 0.63% 0.63%
1.16% 0.95% 0.95% 0.61% 0.71% 0.68% 0.68% 0.68% 0.68% 0.71% 1.28% 1.22%
24.76% 25.24% 25.14% 25.53% 25.37% 25.40% 25.20% 24.61% 25.09% 25.07% 24.49% 24.54%
No. of Shareholders 1,4961,5441,6131,7581,9372,0401,9911,8961,8221,8321,8871,928

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls